MARKET

XTNT

XTNT

Xtant Medical
AMEX
0.4800
-0.0244
-4.84%
Closed 15:59 05/13 EDT
OPEN
0.5045
PREV CLOSE
0.5044
HIGH
0.5200
LOW
0.4701
VOLUME
299.58K
TURNOVER
--
52 WEEK HIGH
0.9500
52 WEEK LOW
0.4380
MARKET CAP
67.23M
P/E (TTM)
14.50
1D
5D
1M
3M
1Y
5Y
1D
Xtant Medical raises FY 2026 revenue guidance to $101M-$105M as it adds HEMOBLAST distribution rights
Seeking Alpha · 1h ago
BTIG Reiterates Buy on Xtant Medical Holdings, Maintains $1 Price Target
Benzinga · 3h ago
Xtant Medical Hldgs Q1 2026 Earnings Call Transcript
Benzinga · 8h ago
Xtant Medical reports Q1 EPS (2c) vs. 0c last year
TipRanks · 8h ago
Xtant Medical raises FY26 revenue view to $101M-$105M from $95M-$99M
TipRanks · 8h ago
Xtant Medical Updates Q1 Results and Raises 2026 Guidance
TipRanks · 10h ago
Xtant Medical GAAP EPS of -$0.02, revenue of $20.9M, raises FY guidance
Seeking Alpha · 10h ago
*Xtant Medical Holdings Raises 2026 View To Rev $101M-$105M >XTNT
Dow Jones · 10h ago
More
About XTNT
Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. The Company's products serve the specialized needs of orthopedic and neurological surgeons, as well as trauma, foot and ankle, sports medicine, wound care surgeons including orthobiologics for the promotion of bone healing, amniotic tissue and collagen for both surgical repair and chronic wound care, implants and instrumentation for the treatment of spinal disease. Its orthobiologics products include OsteoSponge, OsteoSelect DBM Putty, OsteoSelect PLUS DBM Putty, 3Demin, OsteoFactor Pro, OsteoVive Plus, and nanOss. Its spinal implant product categories include cervical, thoracolumbar, sacroiliac joint, and interbody. The Company has exclusive United States distribution rights to Dilon's HEMOBLAST Bellows.

Webull offers Xtant Medical Holdings Inc stock information, including AMEX: XTNT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XTNT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XTNT stock methods without spending real money on the virtual paper trading platform.